Financials
- Market Capitalization 628.14 M
- Employee 752
- Founded 2014
- CEO Christian Itin
- Website www.autolus.com
- Headquarter United Kingdom
- FIGI BBG00KVT05R6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2774 | SLN Silence Therapeutics Plc - American Depository Share | 13.45 USD | -0.59% | +2.13% | +17.78% | +163.73% | 635.47 M USD | ||
| 2784 | ALT Altimmune, Inc. - Common Stock | 3.24 USD | +2.86% | +8.72% | +8.00% | -12.90% | 630.24 M USD | ||
| 2796 | RGNX REGENXBIO Inc. - Common Stock | 9.37 USD | -0.11% | -15.89% | -2.90% | -30.23% | 618.54 M USD | ||
| 2814 | ARVN Arvinas, Inc. - Common Stock | 9.24 USD | -0.86% | +2.44% | +12.96% | -0.65% | 604.17 M USD |
Frequently asked questions about Autolus Therapeutics plc American Depositary Share
What is the Autolus Therapeutics plc American Depositary Share stock price today?
The current price of Autolus Therapeutics plc American Depositary Share (AUTL) is 2.36. Over the past 24 hours, the stock has changed by +1.29%. Follow the AUTL chart for real-time price dynamics.
What is the stock ticker of Autolus Therapeutics plc American Depositary Share?
Autolus Therapeutics plc American Depositary Share trades under the ticker AUTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Autolus Therapeutics plc American Depositary Share stock going up?
AUTL has changed by -3.28% over the last week, +62.76% over the last month, and +49.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Autolus Therapeutics plc American Depositary Share?
Autolus Therapeutics plc American Depositary Share currently has a market capitalization of 628.14 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Autolus Therapeutics plc American Depositary Share earnings last quarter?
Last quarter, Autolus Therapeutics plc American Depositary Share reported earnings of -0.15 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Autolus Therapeutics plc American Depositary Share revenue for the last quarter?
Autolus Therapeutics plc American Depositary Share reported quarterly revenue of 45.69 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Autolus Therapeutics plc American Depositary Share net income for the last quarter?
Autolus Therapeutics plc American Depositary Share reported net income of -39.11 M for the last quarter. The previous quarter showed -71.6 M, which means net income changed by +45.37%.
How many employees does Autolus Therapeutics plc American Depositary Share have?
As of the latest available data, Autolus Therapeutics plc American Depositary Share has 752 employees. Workforce size can provide additional context about the company's scale and operations.
What is Autolus Therapeutics plc American Depositary Share EBITDA?
Autolus Therapeutics plc American Depositary Share EBITDA is -46.35 M, and its EBITDA margin is -101.46%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Autolus Therapeutics plc American Depositary Share stock?
You can buy Autolus Therapeutics plc American Depositary Share (AUTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Autolus Therapeutics plc American Depositary Share stock?
Investing in Autolus Therapeutics plc American Depositary Share requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AUTL chart and related analysis on metatrader.com as part of your research.